Philips, BioMerieux to Develop Biochips for Cardiovascular Diseases

The deal is the latest for Philips, which is increasingly looking for partners to bring applications to market on its internally developed biosensor and microarray platforms.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.